Artemisinin induces calcium-dependent protein secretion in the protozoan parasite Toxoplasma gondii by Nagamune, Kisaburo et al.




Artemisinin induces calcium-dependent protein
secretion in the protozoan parasite Toxoplasma
gondii
Kisaburo Nagamune
Washington University School of Medicine in St. Louis
Wandy L. Beatty
Washington University School of Medicine in St. Louis
L. David Sibley
Washington University School of Medicine in St. Louis
Follow this and additional works at: http://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Nagamune, Kisaburo; Beatty, Wandy L.; and Sibley, L. David, ,"Artemisinin induces calcium-dependent protein secretion in the
protozoan parasite Toxoplasma gondii." Eukaryotic Cell.6,11. 2147-2156. (2007).
http://digitalcommons.wustl.edu/open_access_pubs/1874
  Published Ahead of Print 31 August 2007. 
2007, 6(11):2147. DOI: 10.1128/EC.00262-07. Eukaryotic Cell 
Kisaburo Nagamune, Wandy L. Beatty and L. David Sibley
 
 Toxoplasma gondii
Protein Secretion in the Protozoan Parasite 
Artemisinin Induces Calcium-Dependent
http://ec.asm.org/content/6/11/2147






This article cites 50 articles, 24 of which can be accessed free
CONTENT ALERTS
 more»articles cite this article), 
Receive: RSS Feeds, eTOCs, free email alerts (when new
http://journals.asm.org/site/misc/reprints.xhtmlInformation about commercial reprint orders: 





ber 25, 2013 by W











ber 25, 2013 by W







EUKARYOTIC CELL, Nov. 2007, p. 2147–2156 Vol. 6, No. 11
1535-9778/07/$08.000 doi:10.1128/EC.00262-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
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Intracellular calcium controls several crucial cellular events in apicomplexan parasites, including protein
secretion, motility, and invasion into and egress from host cells. The plant compound thapsigargin inhibits the
sarcoplasmic-endoplasmic reticulum calcium ATPase (SERCA), resulting in elevated calcium and induction of
protein secretion in Toxoplasma gondii. Artemisinins are natural products that show potent and selective
activity against parasites, making them useful for the treatment of malaria. While the mechanism of action is
uncertain, previous studies have suggested that artemisinin may inhibit SERCA, thus disrupting calcium
homeostasis. We cloned the single-copy gene encoding SERCA in T. gondii (TgSERCA) and demonstrate that
the protein localizes to the endoplasmic reticulum in the parasite. In extracellular parasites, TgSERCA
partially relocalized to the apical pole, a highly active site for regulated secretion of micronemes. TgSERCA
complemented a calcium ATPase-defective yeast mutant, and this activity was inhibited by either thapsigargin
or artemisinin. Treatment of T. gondii with artemisinin triggered calcium-dependent secretion of microneme
proteins, similar to the SERCA inhibitor thapsigargin. Artemisinin treatment also altered intracellular cal-
cium in parasites by increasing the periodicity of calcium oscillations and inducing recurrent, strong calcium
spikes, as imaged using Fluo-4 labeling. Collectively, these results demonstrate that artemisinin perturbs
calcium homeostasis in T. gondii, supporting the idea that Ca2-ATPases are potential drug targets in
parasites.
Apicomplexan parasites infect a wide range of animals, in-
cluding humans, using a process of active penetration of their
host cells (41). This important group of parasites includes
Plasmodium spp., the causative agents of malaria, and the
opportunistic pathogens Cryptosporidium spp. and Toxoplasma
gondii. Host cell invasion by these parasites relies on regulated
secretion of adhesins from apical secretory organelles called
micronemes (3). Microneme secretion in T. gondii is governed
by changes in cytosolic calcium ([Ca2]i) levels in the parasite,
which control gliding motility, cell invasion, and egress (6, 27,
34, 48). Similar studies have demonstrated a role for [Ca2]i in
secretion and motility by Cryptosporidium parvum (7) and Plas-
modium berghei (14). Although these previous studies indicate
an important role for alterations in [Ca2]i), the molecular
mechanisms controlling calcium signaling in parasites are not
well understood.
In eukaryotic cells, [Ca2]i is maintained at an 10,000
lower level than the extracellular environment (1). A system of
calcium channels and pumps maintains this steep gradient and
allows for selective increases in [Ca2]i, which function as a
second messenger (1). Apicomplexans are also capable of
maintaining a steep calcium gradient with low resting levels of
[Ca2]i. Quantitative measurements using fura-2 in T. gondii
indicate that [Ca2]i levels are 100 nM in resting cells (33).
Apicomplexans possess several stores of calcium, including
acidocalcisomes, the mitochondrion, and the endoplasmic re-
ticulum (ER) (32). Of these potential calcium stores, the ER is
the most likely source for rapid release and reuptake of cal-
cium needed to control secretion and motility. Previous studies
using pharmacological inhibitors indicate that T. gondii re-
sponds to agonists of both IP3 and ryanodine-type receptors
and that stimulation of these channels releases Ca2 and stim-
ulates parasite gliding and microneme secretion (8, 26). Per-
turbation of [Ca2]i levels not only blocks secretion but also
prevents motility and cell invasion (27). Fluorescent imaging
studies using calcium-sensitive dyes have revealed that [Ca2]i
levels in the parasite oscillate during parasite gliding (27, 49)
and are elevated during host cell contact (48). However, a
prolonged increase of calcium is toxic as shown by treatment
with caffeine, which elevates [Ca2]i and abolishes the natural
oscillations in calcium seen in motile parasites (49). These
findings indicate an important role for reuptake of calcium to
dampen signaling and refill intracellular stores.
Recent phylogenetic analysis of the apicomplexan genomes
(i.e., Plasmodium, Cryptosporidium, and Toxoplasma) indicates
highly conserved complement of P-type Ca2 ATPases (36).
These particular apicomplexans contain a single orthologue
each of the sarcoplasmic ER Ca2 ATPase (SERCA), also
referred to as ATPase6 in P. falciparum (21). These apicom-
plexans also contain an orthologue of the yeast PMR1 trans-
porter (36), which has previously been called ATPase4 in P.
falciparum, where it is reported to localize to the plasma mem-
brane of asexual stages (11). In addition, apicomplexans con-
tain several additional Golgi-ER-type Ca2 ATPases and a
single Ca2/H exchanger (36). The precise roles played by
these Ca2 ATPases in calcium homeostasis and signaling have
not been addressed by functional studies. Uniquely, T. gondii
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contains two plasma membrane-type Ca2 ATPases, which are
apparently absent from Plasmodium and Cryptosporidium. One
of these genes, TgA1 (named for T. gondii plasma membrane
calcium ATPase 1), has previously been characterized as a
component of both the plasma membrane and the acidocalci-
some (29). Disruption of TgA1 leads to decreased polyphos-
phate content, increases in basal [Ca2]i, and impaired inva-
sion (28), demonstrating that calcium homeostasis is critical
for intracellular survival.
SERCA is one of best characterized P-type ATPases, which
are defined by the existence of a phosphorylated intermediate
during their catalytic cycle (50). Each SERCA protein trans-
ports two Ca2 ions from the cytoplasm to the lumen of the
ER using the energy from hydrolysis of one ATP molecule
(44). SERCA consists of 10 transmembrane regions (M1 to
M10) and three cytoplasmic domains (A domain, actuator; N
domain, nucleotide binding; and P domain, phosphorylation)
(46). The reaction mechanism involves transformation be-
tween two conformational states known as E1 and E2, result-
ing in binding of calcium on the cytoplasmic side and release
into the lumen of the ER (44, 50). Thapsigargin, a sesquiter-
pene lactone produced by the plant Thapsia garganica, locks
the protein in the E2 form, which has a lower affinity for
calcium, thus blocking activity (38, 39, 43).
Artemisinin is also a sesquiterpene lactone that is produced
by the plant Artemisia annua. Artemisinin and related com-
pounds such as artemether and artesunate contain an endo-
peroxide ring that is crucial for activity (18). In Plasmodium,
the SERCA orthologue, PfATP6, was proposed as a target of
the antimalarial drug artemisinin, based on heterologous ex-
pression studies in Xenopus oocytes (12). Artemisinins also
disrupt the growth of Trypanosoma cruzi and inhibit calcium-
dependent ATPase activity in membrane fractions from the
parasite (31). Artemisinin and related compounds are also
effective against T. gondii in vitro; however, they are not used
clinically to treat toxoplasmosis due to relatively low efficacy
(19, 20, 40).
To explore the molecular mechanism of inhibition by ar-
temisinin, we cloned the SERCA homologue of T. gondii
(TgSERCA), demonstrated it functions as a Ca2 ATPase,
and tested its sensitivity to artemisinin.
MATERIALS AND METHODS
Compounds. Artemisinin (98% pure) (CID: 452191), thapsigargin (90%
pure) (CID: 5321923), and caffeine (98% pure) (CID: 64119) were obtained
from Sigma (St. Louis, MO). BAPTA and BAPTA-AM (95% pure) were
obtained from Molecular Probes (Invitrogen, Carlsbad, CA). Compounds were
dissolved in dimethyl sulfoxide (DMSO; Sigma) and stored at 80C until use.
Parasites and culture. T. gondii strain RH (ATCC 50838), clone 2F (ATCC
50839) that expresses bacterial -galactosidase (10) was propagated as
tachyzoites in human foreskin fibroblast cells (HFF) grown in D10 medium
(Dulbecco modified Eagle medium, 10 mM HEPES, 44 mM sodium bicarbonate,
10% fetal bovine serum, 2 mM glutamine, 10 g/ml of gentamicin).
Assay for mitochondrial membrane potential. Purified parasites were treated
with artemisinin in normal growth medium for 2 to 6 h and washed three times
with phosphate-buffered saline (PBS) containing 100 M CaCl2 by centrifuga-
tion at 400  g for 10 min. Parasite cells were resuspended in 1 ml of PBS
containing 2 mM CaCl2 with 2 M rhodamine-123 (Invitrogen/Molecular
Probes), incubated for 30 min at room temperature, washed three times, and
resuspended in PBS containing calcium. Mitochondrial electrochemical potential
was monitored by using a FACSCalibur instrument (Becton Dickinson Bio-
sciences, San Jose, CA) (excitation at 480 nm and emission at 530 nm).
Cloning of TgSERCA. TgSERCA was identified by BLASTX search against
the T. gondii genome database (http://www.toxodb.org/) using SERCA homo-
logues from human (GenBank no. NP_775293), Arabidopsis thaliana
(NP_191999), and Plasmodium falciparum (Q08853) as query sequences. The
full-length cDNA was cloned from the RH strain (ATCC 50838) using the
SMART RACE cDNA amplification kit (Clontech, Mountain View, CA). Pre-
dicted amino acid sequences were aligned by CLUSTAL W (http://www.ebi.ac
.uk/clustalw/). Hydrophobicity profiles were analyzed by using the Kyte and
Doolittle method (http://bioinformatics.weizmann.ac.il/hydroph/plot_hydroph
.html). Transmembrane regions were predicted by the TMPRED program (http:
//www.ch.embnet.org/software/TMPRED_form.html), and the domain structures
were analyzed by InterProScan (http://www.ebi.ac.uk/InterProScan/).
Yeast complementation. Saccharomyces cerevisiae strain K616 (9) was trans-
formed with TgSERCA/pYES2 or empty vector and grown in liquid uracil-
deficient synthetic complete medium at 30°C overnight. The allele of TgSERCA
that was used for yeast expression studies differed in several residues (N562S,
L1043P) from the GenBank entry for TgSERCA (AAU93917). These differ-
ences were presumably due to mutations acquired during PCR amplification of
cDNA; however, since they do not occur in critical residues they were not
repaired. Cells were inoculated into medium with galactose as a carbon source
instead of glucose at an initial optical density at 600 nm (OD600) of 0.01. EGTA,
or EGTA plus thapsigargin, artemisinin, or caffeine were added to the medium
and cultures were incubated 24 to 48 h at 30°C. After the incubation, growth was
measured by absorbance at OD600. Each experiment was repeated three times,
and differences in the means were compared by using the Student t test.
Fluo-4 calcium monitoring. Calcium monitoring was conducted using Fluo-4
as described previously (27, 49). Briefly, freshly egressed parasites were labeled
with 250 nM Fluo-4-AM (Molecular Probes) for 5 to 10 min at room tempera-
ture, followed by centrifugation at 400  g for 5 min and washing in Ringer’s
solution. Parasites were resuspended in Ringer’s solution containing 2 mM
CalCl2 and 1% fetal bovine serum (FBS) and treated with 10 to 50 M arte-
misinin, 0.5 to 1.0 M thapsigargin, or 1% DMSO as a control. After the
addition of drug, cells were added directly to 35-mm glass-bottom microwell
dishes (MatTek, Ashland, MA) and imaged over a 15- to 20-min period using a
temperature-controlled stage (Medical Systems, Greenvale, NY). Cells were
examined by using epifluorescence illumination with a 100-W mercury source on
a Axiovert microscope equipped with a fluorescein isothiocyanate filter set
(XF23; Omega Optical, Brattleboro, VT) using a 63 lens (NA 1.35). Images
were captured at five frames/second by using an Orca ER low-light level camera
(Hamamatsu, Inc., Japan) using Openlab v 4.1 (Improvision, Lexington, MA)
software. Quantitative analysis of image pixel intensity was performed by using
Openlab measurement module and graphed in Excel.
Expression of recombinant protein and generation of anti-TgSERCA anti-
body. The P and N domains of TgSERCA (nucleotides 1117 to 2415, correspond-
ing to amino acid residues 373 to 805) were cloned into the NdeI-HindIII sites
of pET-22b() (EMD Biosciences Novagen, La Jolla, CA) to generate fusions
containing a C-terminal His6 tag. Expression was induced in Escherichia coli
BL21 by the addition of 1 mM IPTG (isopropyl--D-thiogalactopyranoside) for
24 h at 25°C, and the resulting protein was purified by using the ProBond
purification system (Invitrogen). CD1 outbred mice were immunized with 10 g
each of purified polypeptide and Freund complete adjuvant (Sigma-Aldrich, St.
Louis, MO), followed by two boosts of antigen in incomplete adjuvant. SERCA
was detected in parasite or HFF lysates that were resolved on SDS-PAGE and
Western blotted with antibodies to TgSERCA (dilution 1:15,000). Signals were
detected using goat anti-mouse or goat anti-rabbit conjugated to horseradish
peroxidase (dilution 1:10,000; Jackson Immunoresearch Laboratories, West
Grove, PA) and SuperSignal West Pico (Pierce, Rockford, IL).
Immunofluorescence microscopy. Intracellular and extracellular parasites
were processed for immunofluorescence microscopy as described previously
(27). Briefly, cells were fixed with 4% formaldehyde for 20 min, permeabilized by
0.5% Triton X-100, and blocked in 10% FBS in PBS. Mouse anti-TgSERCA
antiserum was used at 1:5,000 dilution. Anti-yeast V-ATPase 100-kDa subunit
monoclonal antibody 10D7 (Invitrogen/Molecular Probes) was used at a 1:100
dilution. RH strain expressing green fluorescent protein (GFP)-HDEL was pro-
vided by Kristen Hager (Notre Dame University). T. gondii was incubated with
a MitoTracker (Molecular Probes; final concentration, 0.5 M) in D10 at 37°C
for 45 min and then rinsed three times with 5 ml of fresh D10 at 37°C for 5 min.
Samples were examined on a Axioscop-2 Mot Plus microscope (Carl Zeiss,
Thornwood, NJ) equipped for epifluorescence microscopy (DAPI [4,6-di-
amidino-2-phenylindole], fluorescein isothiocyanate, and Texas Red filter cubes
[Chroma Technology Corp., Rockingham, VT]). Images were acquired by using
a 1.4 NA 100 Plan-Apochromat lens, captured by an AxioCam MRm CCD
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(Zeiss), and processed by using Axiovision software v4.5 (Zeiss). Images were
deconvolved by using an inverse filter algorithm.
Electron microscopy. For immuno-electron microscopy, parasites were fixed in
4% paraformaldehyde (Polysciences, Inc., Warrington, PA) in 100 mM phos-
phate buffer (pH 7.2) for 30 min at room temperature. Immunolabeling and
silver enhancement were carried out prior to embedding as follows. Fixed par-
asites were washed in blocking buffer (5% FBS, 5% normal goat serum, 0.05%
saponin, 100 mM phosphate) and subsequently incubated for 30 min with mouse
anti-SERCA or rabbit anti-GFP antibodies (ab6556; AbCam, Inc., Cambridge,
MA) diluted in blocking buffer. Samples were washed in phosphate buffer and
probed for 30 min with nanogold anti-mouse or anti-rabbit conjugates (Nano-
probes, Yaphank, NY) diluted in blocking buffer. Samples were washed in
phosphate buffer and fixed for 15 min with 1% glutaraldehyde (Polysciences) in
phosphate buffer. Samples were silver enhanced for 10 min by using an LI silver
enhancement kit (Nanoprobes), washed in water, embedded in 10% gelatin, and
infiltrated overnight with 2.3 M sucrose and 20% polyvinylpyrrolidone in PIPES
[piperazine-N,N-bis(2-ethanesulfonic acid)]–MgCl2 at 4°C. Samples were
trimmed, frozen in liquid nitrogen, and sectioned with a Leica Ultracut UCT
cryo-ultramicrotome (Leica Microsystems, Inc., Bannockburn, IL). Ultrathin
sections (70 nm) were stained with 0.3% uranyl acetate and 2% methylcellu-
lose and then viewed with a JEOL 1200EX transmission electron microscope
(JEOL USA, Inc., Peabody, MA).
MIC2 secretion assay. Microneme secretion assays were performed as de-
scribed previously (5, 26). Briefly, freshly egressed parasites were suspended in
assay medium (Dulbecco modified Eagle medium with 44 mM sodium bicarbon-
ate, 20 mM HEPES, 2 mM glutamine, 10 g of gentamicin/ml, and 3% FBS) and
treated with different concentrations of calcium agonists for 5 or 10 min at 18°C.
In some experiments, parasites were pretreated with 50 M BAPTA-AM or 1
mM BAPTA (Molecular Probes) for 20 min at 18°C to chelate intracellular and
extracellular calcium, respectively, or with DMSO. Treated cells were then in-
cubated for 10 min at 18°C with 10 M artemisinin or 1% ethanol as a positive
control. After treatments, parasites were transferred to 37°C for 2 min to allow
secretion, chilled on wet ice, and separated into the supernatant and cell pellet
by centrifugation at 400  g. Proteins were resolved by sodium dodecyl sulfate-
15% polyacrylamide gel electrophoresis, transferred onto nitrocellulose mem-
branes, and Western blotted with rabbit anti-MIC2 antibody (1:10,000) or mouse
anti--galactosidase monoclonal antibody 40a-1 (1:300) and horseradish perox-
idase-conjugated goat anti-rabbit or mouse immunoglobulin G (IgG) (1:10,000)
(Jackson Immunoresearch Laboratories, West Grove, PA). Signals were de-
tected by using SuperSignal West Pico (Pierce).
RESULTS
Characterization of TgSERCA. To identify the SERCA
orthologue from T. gondii (TgSERCA), A. thaliana, and P.
falciparum SERCA orthologues were used to search the
T. gondii genome database (http://www.toxodb.org/) using
TBLASTN. A single SERCA homologue identified in T. gondii
(Draft 3 annotation 44.m02594) shared more than 50% iden-
tity with human, plant, and Plasmodium orthologues (see Fig.
S1 in the supplemental material). The full-length sequence was
determined from amplified cDNA of the RH strain and the re-
sulting predicted protein sequence was deposited in GenBank
(AAU93917). Comparison of the predicted secondary structures
and domain architectures revealed that TgSERCA contained 10
transmembrane regions similar to human and Plasmodium
orthologues (Fig. 1A). TgSERCA also contained conserved
domains found in E1-E2 type calcium ATPases, including a
cation-transporting ATPase N-terminal domain (InterProScan:
IPR004014), an E1-E2 ATPase domain (IPR008250), a haloacid
dehalogenase-like hydrolase domain (IPR005834), and a cation-
transporting ATPase C-terminal domain (IPR006068, Fig. 1B).
TgSERCA also contained conserved amino acid residues that are
predicted to form the Ca2-binding and ATP-binding pockets
(42, 45, 46) (Fig. 1B).
Localization of TgSERCA to the ER in T. gondii. To inves-
tigate the localization of TgSERCA, we generated an anti-
TgSERCA polyclonal antiserum to the phosphorylation (P)
and nucleotide binding (N) domains expressed as a recombi-
nant protein in E. coli (see Materials and Methods). Anti-
TgSERCA sera recognized a single band in parasite cells at
around 120 kDa, which corresponds to the estimated Mr of
TgSERCA, but did not cross-react with host cells by Western
blotting (Fig. 2A). Anti-TgSERCA antiserum was used for
immunofluorescence microscopy of the T. gondii RH strain
expressing GFP-HDEL, which serves as an ER marker (17). In
intracellular parasites, TgSERCA and GFP-HDEL were local-
ized primarily surrounding the nucleus of the parasite and
extending into the cytoplasm (Fig. 2B). The characteristic pat-
tern of this staining and colocalization with GFP-HDEL indi-
cated that TgSERCA is likely localized in the ER in intracel-
lular parasites. However, in extracellular parasites, TgSERCA
had partially relocalized to the apical region in a pattern that
was nonoverlapping with GFP-HDEL (Fig. 2C). A similar re-
FIG. 1. Predicted secondary structure and conserved domains
found in TgSERCA. (A) Hydrophobicity profiles of human
ATPase2A1 (Hs), P. falciparum ATPase6 (Pf), and TgSERCA (Tg).
Black bars indicate putative transmembrane regions. (B) Predicted
domain structure of human ATPase2A1 (hATPase2A1), P. falciparum
ATPase6 (PfATPase6), and TgSERCA. Cation-transporting ATPase
N-terminal domain (Cation transporting-N), E1-E2 ATPase domain,
haloacid dehalogenase-like hydrolase domain (Hydrolase), and cation-
transporting ATPase C-terminal domain (Cation transporting-C) are
shown. Thin vertical bars indicate the essential amino acid residues
that form the Ca2-binding pocket (upper bars) and residues that
interact with ATP (lower bars). Scale bar, 100 amino acids (100AA).





ber 25, 2013 by W







sult was obtained using anti-GFP antibody to localize GFP-
HDEL (data not shown).
The distribution pattern of SERCA in T. gondii parasites
does not resemble micronemes, rhoptries or dense granules, a
result confirmed by electron microscopy below. To determine
whether the vesicular structures stained with anti-TgSERCA
were mitochondria, we costained T. gondii parasites with anti-
TgSERCA antibody and the mitochondrial marker, Mito-
Tracker. The mitochondrion in T. gondii was observed as single
tube-like structure as reported previously (30), and this signal
did not colocalize with that of anti-TgSERCA antibody (Fig.
2D). Furthermore, we investigated whether the staining pat-
tern of TgSERCA was similar to acidocalcisomes, which con-
tain high levels of Ca2 (29). The staining pattern with anti-
vacuolar-ATPase, an acidocalcisome marker (29), revealed
small punctate vesicles that did not appear to be similar to the
extended membranous structures stained with anti-TgSERCA
(Fig. 2E). Although we were unable to perform costaining
studies due to the fact that both antibodies were produced in
mice, we interpret this result to indicate that TgSERCA is not
localized appreciably to acidocalcisomes. Collectively, these
results indicate that in intracellular parasites TgSERCA was
largely localized in the ER with GFP-HDEL, whereas in ex-
tracellular parasites TgSERCA was partially relocalized in a
distinct apical membrane compartment.
To further explore the localization of TgSERCA, we per-
formed cryo-immuno-electron microscopy labeling of T.
gondii. The epitopes recognized by the mouse anti-TgSERCA
proved to be extremely sensitive to fixation, precluding post-
processing immunolabeling (data not shown). Instead, we
FIG. 2. Localization of TgSERCA in T. gondii. (A) Western blot with anti-TgSERCA antibody against T. gondii lysate (Tg) revealed a single
band of 120 kDa, while HFF cell lysate (HFF) was negative. (B) Immunofluorescence staining of intracellular T. gondii. Intracellular parasites
expressing GFP-HDEL were stained with anti-TgSERCA, followed by Alexa-594-conjugated goat anti-mouse IgG (red). The middle panel shows
the signal of GFP-HDEL (green), with a merged image shown at the right. Nuclei were stained with DAPI (blue). Bar, 5 m. (C) Localization
of TgSERCA and GFP-HDEL in extracellular parasites. Panels: left, anti-TgSERCA (red, stained as in panel B); middle, GFP-HDEL (green);
right, merged image. Nuclei were stained with DAPI (blue). Bar, 2 m. (D) Localization of TgSERCA and mitochondrion in extracellular
parasites. Panels: left, stained with mouse anti-TgSERCA followed by Alexa-488-conjugated goat anti-mouse IgG (green); middle, MitoTracker
(red), right, merged image. Nuclei were stained with DAPI (blue). Bar, 2 m. (E) Localization of TgSERCA (upper) and acidocalcisomes (lower)
in separate extracellular parasites. The upper panel was stained with mouse anti-TgSERCA, followed by goat anti-mouse IgG; the lower panel was
stained with anti-V-ATPase, followed by goat anti-mouse IgG. Bar, 2 m. Wide field images were acquired and deconvolved as described in
Materials and Methods. A single mid-Z plane is shown for each example.
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lightly fixed cells, permeabilized them, and performed immu-
nolabeling and silver enhancement prior to embedding (see
Materials and Methods). Staining of TgSERCA confirmed that
in intracellular parasites it was localized in the nuclear enve-
lope and in ER membranes that surround the nucleus (Fig.
3A). Although the intensity of labeling was slightly lower,
GFP-HDEL was also detected in the ER and surrounding
the nuclear envelope (Fig. 3C). In extracellular parasites,
TgSERCA was partially relocalized to apical membranes in the
vicinity of micronemes (arrow, Fig. 3B), while GFP-HDEL
remained associated with the nuclear envelope and proximal
ER (Fig. 3D). The ultrastructural morphology of secretory
organelles in T. gondii is quite distinct, and no specific staining
of micronemes, dense granules, or rhoptries was observed by
cryo-immuno-electron microscopy labeling (Fig. 3D and data
not shown). Control sections stained with an isotype control
antibody remained negative, confirming the specificity of this
technique (Fig. 3E).
Heterologous expression and activity of TgSERCA. To de-
termine whether TgSERCA functions as a Ca2 transporter,
we used the yeast mutant strain K616, which is defective in
both Golgi (PMR1) and vacuolar (PMC1) Ca2 pumps and
also lacks calcineurin (CNB1) (9). Previous reports have shown
that plant (25) and trypanosomal (13) SERCA orthologues
complement the growth of this mutant yeast strain in low-
Ca2 medium. The K616 mutant yeast was transfected with
TgSERCA, and growth was observed in low-calcium medium
containing EGTA. TgSERCA complemented the growth of
the K616 yeast strain in low-Ca2 medium with a maximum
effect seen when growth was inhibited by 10 mM EGTA (Fig.
4A). Thapsigargin, which is a potent SERCA inhibitor (38),
reversed the growth complementing effect of TgSERCA, while
treatment of yeast cells containing a vector control had no
effect (Fig. 4B). The complementing effects of TgSERCA were
not reversed by treatment with caffeine (Fig. 4C), which does
not act directly on TgSERCA, but rather activates a ryanodine-
type calcium release channel (26). Caffeine is known to enter
yeast cells efficiently and to affect kinase signaling (23), al-
though yeast cells lack ryanodine-responsive calcium channels.
We also tested the effects of artemisinin treatment on the
ability of TgSERCA to rescue the K616 mutant yeast grown in
low calcium. The complementation of K616 yeast mutants
grown in low calcium was blocked by treatment with artemisi-
nin (Fig. 4D), a finding consistent with TgSERCA being in-
hibited by this compound. Yeast cells containing the vector
alone were not inhibited by treatment with similar levels of
artemisinin (Fig. 4D). These findings support a functional role
for TgSERCA in restoring calcium homeostasis in this defec-
tive yeast strain. Similar results have been obtained by previous
studies that have used this yeast mutant to study Ca2
ATPases from T. cruzi (13) and from plants (25).
Artemisinin does not affect mitochondrial membrane poten-
tial in T. gondii. A recent report indicated that treatment of
artemisinin causes substantial loss of mitochondrial membrane
potential in S. cerevisiae, albeit it at very high concentrations
(24). Consequently, we investigated whether a similar event
occurs in T. gondii using rhodamine-123, which monitors mi-
tochondrial membrane potential. Treatment of T. gondii with a
high dose of artemisinin (100 M) for 2 h did not alter mem-
brane potential (Fig. 4E), although significant loss was previ-
ously reported by treatment with 8 M artemisinin in yeast
(24). Furthermore, no difference was observed in the mem-
brane potential of T. gondii after incubation with 100 M
artemisinin for 6 h (data not shown). These results indicate
that the mitochondrion is not a primary target of artemisinin in
T. gondii.
Artemisinin induces calcium-dependent secretion in T.
gondii. Microneme secretion in T. gondii is triggered by ele-
vated cytosolic calcium as shown by detection of the soluble
form of MIC2 that is shed into the supernatant following
release onto the cell surface and proteolytic cleavage (4, 5).
Inhibition of TgSERCA by treatment with thapsigargin results
in elevated [Ca2]i, which stimulates microneme secretion (6,
33). We investigated whether treatment with artemisinin would
induce a similar exocytic response by examining cell superna-
tants for the presence of shed MIC2 by Western blotting.
Artemisinin induced the secretion of MIC2 in 5 min when
treated with 100 M, while treatment with lower doses (10
M) required 10 min to detect secretion (Fig. 5A). This effect
was similar, albeit less potent, than that seen with thapsigargin
or ethanol (4), two positive controls that have been validated in
this assay previously (Fig. 5A). The detection of cellular MIC2
in the cell pellet served both as a loading control and to verify
that the effects were not due to lysis, which would have resulted
in loss from this fraction (Fig. 5A). Next, we tested whether
this induction was dependent on cytosolic Ca2. Secretion of
MIC2 by artemisinin was completely reversed by pretreatment
with BAPTA-AM, which is a membrane-permeable Ca2 che-
lator (Fig, 5B). On the other hand, the membrane-impermeable
Ca2 chelator, BAPTA, had only a modest affect on secretion
(Fig. 5B). These results indicate that artemisinin induces the se-
cretion of microneme proteins through a pathway that is largely
dependent on mobilization of intracellular calcium.
Artemisinin induced calcium spikes in T. gondii. Previous
studies have demonstrated that cytoplasmic calcium levels in T.
gondii undergo oscillations that are associated with gliding
motility (27, 49). We used Fluo-4 imaging to evaluate the
effects of artemisinin treatment on intracellular calcium oscil-
lations in T. gondii. Fluo-4 has the advantage of being very
sensitive and rapid, thus making it ideal for temporal measure-
ments, although it is not ratiometric and thus not useful for
measuring calcium concentrations (15). Time-lapse video mi-
croscopy was used to monitor temporal changes in intracellular
calcium after the addition of artemisinin to Fluo-4-labeled
parasites. Representative traces derived from time-lapse re-
cordings are shown in Fig. 6. Treatment with 10 M artemisi-
nin resulted in rapid, repeated oscillations that showed ampli-
tudes similar to those for control parasites (Fig. 6A) but with
an increased periodicity (shorter time between repeated cy-
cles) (Fig. 6B). In parasites treated with 50 M artemisinin, a
second pattern was observed, consisting of strong increases
(4-fold) that appeared quite suddenly and which lasted
longer and were spaced further apart (increased period) com-
pared to control cells (Fig. 6B). In previous studies, it was
observed that calcium oscillations were most commonly ob-
served in cells undergoing gliding (27). However, artemisinin
treatment also induced oscillations in nonmotile cells. A high
frequency of total cells responded (up to 50% of the popula-
tion), and yet responses were not synchronous and at any given
time only 5 to 10% of cells exhibited oscillations. Removal of
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FIG. 3. Immuno-electron microscopy localization of TgSERCA versus GFP-HDEL in T. gondii. TgSERCA localized to perinuclear ER in both
intracellular and extracellular parasites. In extracellular parasites, SERCA labeling extended into the apical region of parasites where it was
associated with vesicular structures (apical region indicated by arrows). (A) Intracellular T. gondii immunolabeled with mouse anti-TgSERCA
antibody. (B) Extracellular T. gondii immunolabeled with mouse anti-TgSERCA antibody. (C) Intracellular T. gondii expressing GFP-HDEL
immunolabeled with rabbit anti-GFP antibody. (D) Extracellular T. gondii expressing GFP-HDEL immunolabeled with rabbit anti-GFP antibody.
(E) Intracellular T. gondii immunolabeled with isotype control antibody. N, parasite nucleus; DG, dense granules; G, position of the Golgi. Scale
bars, 0.5 m. Note that the variable size of gold particles seen here is due to the silver enhancement technique. To facilitate identification of gold
particles, representative clusters are highlighted by red circles.
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extracellular calcium from the medium and addition of 5 mM
EGTA did not affect the amplitude or periodicity of calcium
oscillations in control or artemisinin-treated cells (data not
shown), indicating that the source of calcium is from the re-
lease of intracellular stores.
In parasites treated with thapsigargin, altered calcium oscil-
lations were also observed (Fig. 6C), although there were sev-
eral differences from the responses seen with artemisinin. First,
the average level of intracellular calcium was elevated by thap-
sigargin (Fig. 6), a result not seen with artemisinin. Second,
thapsigargin induced both slow calcium spikes with higher am-
plitude and longer periodicity and short, rapid oscillations (Fig.
6C). Finally, the effects of thapsigargin were noted at doses of
0.5 M, 10-fold lower than similar responses seen with arte-
misinin (Fig. 6).
To provide a more complete summary of the changes in
calcium oscillations,25 individual time lapse recordings were
analyzed for each condition to determine the time interval
between each cycle (period), and the data were plotted as a
histogram (Fig. 6D). Changes in the periodicity of calcium
oscillations that were induced by artemisinin were very appar-
ent. Treatment with 10 M artemisinin resulted in a faster
periodicity with an average time of 13.95 s (	4.4) compared to
22.6 s (	3.5) for control cells (Fig. 6D). In contrast, treatment
with 50 M artemisinin resulted in two responses: cells that
responded with average cycle time of 21 to 30 s, similar to
controls, and cells that exhibited strong calcium spikes that
lasted much longer (Fig. 6D). This biphasic pattern resulted in
an average period of 33.8 s (	15.6). Finally, treatment with low
FIG. 4. Complementation of calcium-ATPase deficient yeast strain
K616 by TgSERCA. (A) Growth of K616 yeast in medium supple-
mented with EGTA. K616 cells were transformed with TgSERCA
(solid line) or empty vector (dashed line). Growth was measured by
absorbance at OD600 after growth for 48 h (see Materials and Meth-
ods) with different levels of EGTA. (B) Inhibition of yeast K616
complementation with TgSERCA by treatment with thapsigargin. f,
TgSERCA; , empty vector. Transformants were inoculated in me-
dium supplemented with 10 M EGTA and 0 to 10 M thapsigargin
(TG). Growth was measured at OD600 after 24 h of incubation. As-
terisk indicates significantly different (P
 0.02) versus no thapsigargin.
(C) Caffeine did not reverse the complementation of yeast K616 with
TgSERCA. TgSERCA or empty vector transformants were inoculated
in medium with 10 M EGTA and 0 to 1,000 M caffeine. (D) Inhi-
bition of TgSERCA by artemisinin treatment of yeast K616 mutant. f,
TgSERCA;, empty vector. Transformants of K616 were inoculated in
medium supplemented with 10 M EGTA and 0 to 100 M artemisi-
nin (ART). Growth was measured at OD600 after 24 h of incubation.
Single and double asterisks indicate a significant difference (P  0.05
and P  0.01, respectively) versus no artemisinin. (E) Artemisinin did
not affect mitochondrial membrane potential of T. gondii. Extracellular
parasites were treated with 0 to 100 M artemisinin (ART) for 2 h and
stained with rhodamine-123. The fluorescence intensity was monitored
by fluorescence-activated cell sorting, and the FL1-H channel was set
to detect rhodamine-123.
FIG. 5. Induction of MIC2 secretion by extracellular parasites as
detected by Western blotting of cell fractions. (A) Treatment with
artemisinin causes a dose-dependent release of MIC2 into the super-
natant (compare 10 M versus 100 M at 5 min). Parasites were
pretreated with artemisinin (ART), thapsigargin (TG), or 1% of
ethanol (EtOH) for 5 or 10 min at 18°C (to block premature secre-
tion), followed by stimulation of secretion at 37°C for 2 min. Samples
were divided into supernatant and cell pellet and analyzed by Western
blotting with anti-MIC2 antibody (supernatant) or anti--galactosidase
(cell pellet). (B) Chelation of intracellular calcium by BAPTA-AM
inhibited secretion induced by artemisinin (ART), while chelation of
extracellular calcium by BAPTA had minimal effect. Parasites were
pretreated with BAPTA or BAPTA-AM at 18°C for 20 min to chelate
calcium, followed by treatment with 10 M artemisinin or 1% ethanol
for 10 min at 18°C, and finally stimulation of secretion at 37°C for 2
min, as detailed in Materials and Methods. Samples were analyzed as
in panel A.
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doses of thapsigargin (0.5 M) induced both more rapid, shal-
low oscillations and longer spikes with greater amplitude, lead-
ing to a broad distribution of cycles (Fig. 6D). Collectively,
these results confirm that artemisinin and thapsigargin cause
similar changes in calcium oscillations, inducing both rapid
shallow oscillations and prolonged spikes in intracellular cal-
cium.
DISCUSSION
We have explored the function of the Ca2ATPase SERCA
in T. gondii in order to determine its role in calcium homeosta-
sis and to investigate the molecular basis of inhibition by sev-
eral plant sesquiterpene lactones. Our results indicate that T.
gondii has a single functional SERCA based on the following
evidence: (i) BLASTP similarity and phylogenetic grouping
with known SERCA enzymes (36), (ii) conserved domain
structure and presence of critical Ca2 binding and ATPase
residues, (iii) functional rescue of yeast cells defective in Ca2
ATPases, and (iv) inhibition by thapsigargin, a known inhibitor
of SERCA Ca2 ATPases (38). TgSERCA is localized to the
ER of T. gondii, where it likely participates in controlling
calcium stores that are important for microneme secretion and
motility. We also demonstrate that artemisinin (i) triggers cal-
cium-dependent secretion of microneme proteins in T. gondii,
(ii) inhibits the functional rescue of yeast mutants expressing
TgSERCA, and (iii) induces sustained calcium spikes in T.
gondii. Collectively, our studies indicate that artemisinin affects
calcium homeostasis and signaling in the parasite, supporting
the conclusions that it acts as an inhibitor of SERCA.
T. gondii has a highly polarized secretory pathway with the ER
being an extension of the nuclear envelope: the major site of exit
from the ER occurs at the apical surface of the nuclear envelope,
leading to a juxtanuclear, stacked Golgi and extending to apical
secretory organelles (17). Immunolabeling of TgSERCA con-
firmed it is located in the ER, where it largely overlaps with GFP
containing the C-terminal ER retention sequence HDEL. Sur-
prisingly, the distribution of TgSERCA was somewhat different in
extracellular parasites, where the protein was partially found in
FIG. 6. Calcium oscillations in T. gondii induced by artemisinin or thapsigargin. Fluo-4-loaded parasites were imaged by using time-lapse
fluorescence video microscopy, and the relative intensity of fluorescence, reflecting intracellular calcium levels, was plotted versus time. (A) Con-
trol cells showed repeated oscillations. (B) Treatment with 10 M artemisinin (red) resulted in more rapid oscillations of similar amplitude but
shorter period compared to the control. Treatment with 50 M artemisinin (yellow) resulted in slower oscillations of much higher amplitude and
longer period. (C) Treatment with 0.5 M thapsigargin resulted in elevated average levels of calcium and in both slow calcium spikes of higher
amplitude and short rapid oscillations. (D) Histogram analysis of the periodicity of cycles exhibited by control cells (blue, CTL), 10 M artemisinin
(red, ART 10), 50 M artemisinin (yellow, ART 50), and 0.5 M thapsigargin (green, TG 0.5).





ber 25, 2013 by W







apical membranes that were localized near micronemes. This
pattern was not shared by GFP-HDEL, which was retained near
the nuclear envelope, suggesting that the ER becomes partitioned
in extracellular parasites. Other cells also develop specialized
membranes in locations that are important for local calcium con-
trol. For example, SERCA orthologues are present in the vacuole
in plant cells (37) and alveolar sacks in ciliates (22). The distri-
bution of the TgSERCA-containing vesicles to the apex may be
important for rapid release and effective recovery of cytosolic
Ca2, events that likely govern both motility and microneme
secretion.
Artemisinin treatment of T. gondii resulted in calcium-de-
pendent secretion of microneme proteins as detected by re-
lease of MIC2 into the supernatant, similar to the SERCA
inhibitor thapsigargin. While artemisinin treatment was less
potent than thapsigargin, it exhibited a dose- and time-depen-
dent induction of microneme secretion in T. gondii. Induction
of microneme secretion by both artemisinin and thapsigargin
was inhibited by chelation of intracellular calcium, while being
much less influenced by extracellular calcium. These results are
consistent with both agents acting to release intracellular cal-
cium stores, thus leading to elevated cytosolic calcium that
triggers microneme secretion. TgSERCA was shown to com-
plement a yeast strain that is defective in Ca2 transport, thus
establishing it is a functional Ca2 transporter. TgSERCA
expressed in this heterologous system was sensitive to thapsi-
gargin, similar to SERCA orthologues in animal cells. The
ability of TgSERCA to complement deficient yeast was also
inhibited by artemisinin. The potency of artemisinin in inhib-
iting the complementation of K616 yeast by TgSERCA and in
stimulating parasite secretion was similar, suggesting it acts on
the parasite by inhibiting SERCA.
Thapsigargin inhibits SERCA by locking it in the E2 con-
formation, thus preventing calcium pumping (38, 39). Inhibi-
tion of SERCA would be expected to prevent the reuptake into
the ER, resulting in higher cytosolic calcium levels. Previous
studies of pancreatic B cells have shown that calcium oscilla-
tions can be perturbed by thapsigargin, resulting in a pattern of
stronger calcium spikes (16). A similar response to treatment
with thapsigargin was apparent in Fluo-4 monitoring of cal-
cium levels in T. gondii in the present study. While artemisinin
did not lead to higher resting levels of [Ca2]i, it did pro-
foundly increase the periodicity and duration of calcium spikes
in T. gondii. This behavior mimics the effects of thapsigargin on
calcium oscillations by T. gondii, although thapsigargin was
considerably more potent. The reason why the two compounds
result in different profiles of calcium oscillations is uncertain
but could result from differences in binding to the target and
thus how they affect the cycling between the E1 and E2 con-
formations of the SERCA pump.
Previous studies have shown that during gliding motility,
[Ca2]i levels in T. gondii undergo periodic oscillations that
are dramatically dampened during cell invasion (27). Calcium
oscillations are a common phenomenon during fertilization,
cell migration, and during the cell cycle in a variety of verte-
brate systems from frogs to humans (2). The molecular basis of
the oscillations seen in Toxoplasma is not known, although they
suggest a simple two-component circuit consisting of a calcium
release channel and a reuptake pump (SERCA). The source
for the increase in cytoplasmic calcium is from an intracellular
pool, since the periodicity and amplitude of calcium oscilla-
tions were not affected by removal of calcium from the me-
dium. Calcium release channels have not yet been character-
ized in T. gondii, or for that matter in yeast, protozoa, or plants,
and these organisms do not contain conserved calcium release
channels typical of animal cells (36, 37). The control of calcium
homeostasis is likely to be complex since T. gondii also contains
several other P-type Ca2 ATPases (36), as well as other cation
exchangers (http://ToxoDB.org).
Artemisinin and its derivatives have been used widely as a
therapy for malaria, owing to their extremely potent inhibition
of the parasite (18). This activity may be due to inhibition of
the parasite SERCA as demonstrated by expression studies in
Xenopus (12). In these heterologous systems, artemisinins are
highly selective for malaria SERCA versus mammalian en-
zymes, presumably due to molecular differences in the binding
site within the calcium channel of SERCA (47). Toxoplasma is
also much less sensitive to artemisinin than malaria (19, 20),
although newer variants such as artemisone are considerably
more potent against both organisms (18, 35). Interestingly,
another plant product, ryanodine, also disrupts calcium ho-
meostasis in T. gondii (26); however, its target is calcium re-
lease channels in the ER rather than the reuptake pump
SERCA. Because these agents disrupt calcium homeostasis at
opposing points (i,e., release versus uptake), their collective
action might be expected to be synergistic. Collectively, our
findings indicate an important role for calcium regulation in
the Apicomplexa and support the idea that calcium pumps and
channels are important potential drug targets in parasites.
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